Jump to main content
Jump to site search

Issue 14, 2018
Previous Article Next Article

Combined therapies with nanostructured carbon materials: there is room still available at the bottom

Author affiliations

Abstract

The progress of the chemistry of carbon nanotubes (CNT) and graphene derivatives [mainly graphene oxide (GO)] has produced a number of technologically advanced drug delivery systems (DDS) that have been used in the field of nanomedicine, mostly in studies related to oncology. However, such a demanding field of research requires continuous improvements in terms of efficiency, selectivity and versatility. The loading of two, or more, bioactive components on the same nanoparticle offers new possibilities for treating cancer, efficiently addressing issues related both to biodistribution and pharmacokinetics. Nanostructured carbon materials (NCM), with their high surface area, their efficient cellular membrane crossing and their chemical versatility are ideal candidates for easy hetero-decoration and exploitation as advanced DDS. This review describes the achievements obtained in this area focusing on those studies in which two or more active components were loaded onto the DDS.

Graphical abstract: Combined therapies with nanostructured carbon materials: there is room still available at the bottom

Back to tab navigation

Publication details

The article was received on 15 Jan 2018, accepted on 19 Feb 2018 and first published on 19 Feb 2018


Article type: Review Article
DOI: 10.1039/C8TB00121A
Citation: J. Mater. Chem. B, 2018,6, 2022-2035
  •   Request permissions

    Combined therapies with nanostructured carbon materials: there is room still available at the bottom

    G. Biagiotti, S. Fedeli, G. Tuci, L. Luconi, G. Giambastiani, A. Brandi, F. Pisaneschi, S. Cicchi and P. Paoli, J. Mater. Chem. B, 2018, 6, 2022
    DOI: 10.1039/C8TB00121A

Search articles by author

Spotlight

Advertisements